As if the hundreds of millions of dollars in paid out in damages to injured patients aren't enough, Boston Scientific's ($BSX) troubled vaginal mesh devices have been hit by allegations that they contain a counterfeit material. Boston Sci denies the charge, and says it has a robust quality control system. The FDA said the company is conducting tests on the material to determine if it impacts the safety and efficacy of the mesh. More | Boston Sci release | FDA statement